Investigational Drug Information for LY3549492
✉ Email this page to a colleague
What is the development status for investigational drug LY3549492?
LY3549492 is an investigational drug.
There have been 9 clinical trials for LY3549492.
The most recent clinical trial was a Phase 1 trial, which was initiated on November 13th 2024.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Overweight, and Obesity. The leading clinical trial sponsors are Eli Lilly and Company and [disabled in preview].
Summary for LY3549492
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 7 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2024-11-13) |
| Vendors | 4 |
Recent Clinical Trials for LY3549492
| Title | Sponsor | Phase |
|---|---|---|
| A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity | Eli Lilly and Company | PHASE1 |
| A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus | Eli Lilly and Company | PHASE1 |
| A Study of LY3549492 in Healthy Weight Adult Participants | Eli Lilly and Company | PHASE2 |
Clinical Trial Summary for LY3549492
Top disease conditions for LY3549492
Top clinical trial sponsors for LY3549492
US Patents for LY3549492
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
